“Pretreatment with a phospholipid N-methylation inhibitor 2-methylaminoethane ) precluded the rise in linoleic and palmitic acid-rich DAG, whereas pretreatment with a diglyceride kinase inhibitor (D102) produced a sustained elevation of linoleic and palmitic acid-rich DAG.”